Latest & greatest articles for cyanocobalamin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cyanocobalamin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cyanocobalamin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cyanocobalamin

1. Cyanocobalamin

Cyanocobalamin Top results for cyanocobalamin - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 (...) or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for cyanocobalamin The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence

2018 Trip Latest and Greatest

2. Effect of Toothpaste Fortified With Cyanocobalamin on Vitamin B12 Status

Effect of Toothpaste Fortified With Cyanocobalamin on Vitamin B12 Status Effect of Toothpaste Fortified With Cyanocobalamin on Vitamin B12 Status - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Effect (...) of Toothpaste Fortified With Cyanocobalamin on Vitamin B12 Status The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02679833 Recruitment Status : Completed First Posted : February 10, 2016 Last Update Posted : May 11, 2018 Sponsor: Saarland University Collaborator: Institute of Alternative and Sustainable

2016 Clinical Trials

3. is there any evidence to support the use of oral vitamin b12 (cyanocobalamin) instead of intramuscular preparation (hydroxycobalamin) instead for vitamin b12 deficiency or pernicious anaemia diagnosed

is there any evidence to support the use of oral vitamin b12 (cyanocobalamin) instead of intramuscular preparation (hydroxycobalamin) instead for vitamin b12 deficiency or pernicious anaemia diagnosed is there any evidence to support the use of oral vitamin b12 (cyanocobalamin) instead of intramuscular preparation (hydroxycobalamin) instead for vitamin b12 deficiency or pernicious anaemia diagnosed in primary care? - Trip Database or use your Google+ account Liberating the literature ALL (...) @tripdatabase.com is there any evidence to support the use of oral vitamin b12 (cyanocobalamin) instead of intramuscular preparation (hydroxycobalamin) instead for vitamin b12 deficiency or pernicious anaemia diagnosed in primary care? ATTRACT found mixed evidence on the use of oral vitamin B12 over intramuscular B12. A 2009 Cochrane systematic review (1) compared oral with intramuscular vitamin B12 therapy for Vitamin B12 deficiency. The authors conclude: “The evidence derived from these limited studies

2012 TRIP Answers

4. Characterization of Cyanocobalamin in Healthy Voluteers After Intranasal and Intramuscual Administration

Characterization of Cyanocobalamin in Healthy Voluteers After Intranasal and Intramuscual Administration Characterization of Cyanocobalamin in Healthy Voluteers After Intranasal and Intramuscual Administration - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Characterization of Cyanocobalamin in Healthy Voluteers After Intranasal and Intramuscual Administration The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01306123 Recruitment Status : Completed First Posted : March 1, 2011 Last Update Posted

2011 Clinical Trials

5. Cyanocobalamin nasal spray (Nascobal) for vitamin B12 deficiency: horizon scanning technology briefing

Cyanocobalamin nasal spray (Nascobal) for vitamin B12 deficiency: horizon scanning technology briefing Cyanocobalamin nasal spray (Nascobal) for vitamin B12 deficiency: horizon scanning technology briefing Cyanocobalamin nasal spray (Nascobal) for vitamin B12 deficiency: horizon scanning technology briefing National Horizon Scanning Centre Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality (...) of this assessment has been made for the HTA database. Citation National Horizon Scanning Centre. Cyanocobalamin nasal spray (Nascobal) for vitamin B12 deficiency: horizon scanning technology briefing. Birmingham: National Horizon Scanning Centre (NHSC). 2007 Authors' objectives This study examines the use of Cyanocobalamin nasal spray (Nascobal) for vitamin B12 deficiency. Project page URL Indexing Status Subject indexing assigned by CRD MeSH Vitamin B 12 Deficiency /drug therapy Language Published English

2007 Health Technology Assessment (HTA) Database.

6. Update on oral cyanocobalamin (vitamin b(12)) treatment in elderly patients. (Abstract)

Update on oral cyanocobalamin (vitamin b(12)) treatment in elderly patients. The objective of this review is to evaluate the usefulness of oral cobalamin (vitamin B12) treatment in elderly patients. PubMed was systematically searched for English and French articles published from January 1990 to January 2007. Prospective randomized studies (n=3), a systematic review by the Cochrane group (n=1) and prospective studies in a well defined population (n=5) provide evidence that oral cobalamin (...) therapy may adequately treat cobalamin deficiency in elderly patients. However, the current literature does not suggest a strategy in terms of the form (hydroxy- or cyanocobalamin), frequency and duration of the treatment. This review confirms the previously reported efficacy of oral cobalamin treatment in elderly patients. Oral cobalamin treatment avoids the discomfort, inconvenience and cost of monthly injections.

2008 Drugs & Aging

7. The occurrence of a cyanocobalamin-binding protein in milk and the isolation of a cyanocobalamin-protein complex from sow's milk Full Text available with Trip Pro

The occurrence of a cyanocobalamin-binding protein in milk and the isolation of a cyanocobalamin-protein complex from sow's milk 14351201 2003 05 01 2018 12 01 0264-6021 59 2 1955 Feb The Biochemical journal Biochem. J. The occurrence of a cyanocobalamin-binding protein in milk and the isolation of a cyanocobalamin-protein complex from sow's milk. 329-34 GREGORY M E ME HOLDSWORTH E S ES eng Journal Article England Biochem J 2984726R 0264-6021 0 Carrier Proteins 0 Hematinics 0 Proteins

1955 Biochemical Journal

8. Some properties of the cyanocobalamin-protein complex from sow's milk, and the mode of linkage of cyanocobalamin with protein Full Text available with Trip Pro

Some properties of the cyanocobalamin-protein complex from sow's milk, and the mode of linkage of cyanocobalamin with protein 14351202 2003 05 01 2018 12 01 0264-6021 59 2 1955 Feb The Biochemical journal Biochem. J. Some properties of the cyanocobalamin-protein complex from sow's milk, and the mode of linkage of cyanocobalamin with protein. 335-40 GREGORY M E ME HOLDSWORTH E S ES eng Journal Article England Biochem J 2984726R 0264-6021 0 Proteins P6YC3EG204 Vitamin B 12 OM Animals Female Milk

1955 Biochemical Journal

9. Some observations on the measurement of `binding' of cyanocobalamin by `intrinsic factor' preparations Full Text available with Trip Pro

Some observations on the measurement of `binding' of cyanocobalamin by `intrinsic factor' preparations 13459880 2000 07 01 2018 12 01 0264-6021 66 3 1957 Jul The Biochemical journal Biochem. J. Some observations on the measurement of binding of cyanocobalamin by intrinsic factor preparations. 456-62 GREGORY M E ME HOLDSWORTH E S ES eng Journal Article England Biochem J 2984726R 0264-6021 0 Hematinics 9008-12-2 Intrinsic Factor P6YC3EG204 Vitamin B 12 OM Gastric Juice Hematinics Humans Intrinsic

1957 Biochemical Journal

10. Increase in circulating holotranscobalamin after oral administration of cyanocobalamin or hydroxocobalamin in healthy adults with low and normal cobalamin status. Full Text available with Trip Pro

Increase in circulating holotranscobalamin after oral administration of cyanocobalamin or hydroxocobalamin in healthy adults with low and normal cobalamin status. To investigate the absorption of synthetic cyanocobalamin and natural occurring hydroxocobalamin in populations with low and normal cobalamin (vitamin B12) status.We included adults with low (n = 59) and normal (n = 42) cobalamin status and measured the change in serum holotranscobalamin (ΔholoTC) before and after 2 day administration (...) of different doses of cyanocobalamin and hydroxocobalamin (CobaSorb test). In the low status group, the test was performed using a cross-over design with identical doses of both cobalamin forms (1.5, 3, and 6 µg, respectively). In the normal status group, the test was performed with either 3, 6, and 9 µg cyanocobalamin (n = 28), or with 9 µg cyanocobalamin and 9 µg hydroxocobalamin (n = 14).In both groups, median ΔholoTC (pmol/L) was higher after intake of cyanocobalamin compared to (hydroxocobalamin) [low

2018 European journal of nutrition

11. [Use of the combination of adrenal cortex extract, pyridoxal-5-phosphate, cyanocobalamin and ascorbic acid in the treatment of hypocorticism in pregnancy]. (Abstract)

[Use of the combination of adrenal cortex extract, pyridoxal-5-phosphate, cyanocobalamin and ascorbic acid in the treatment of hypocorticism in pregnancy]. 7121892 1982 12 02 2013 11 21 0026-4784 34 7-8 1982 Jul-Aug Minerva ginecologica Minerva Ginecol [Use of the combination of adrenal cortex extract, pyridoxal-5-phosphate, cyanocobalamin and ascorbic acid in the treatment of hypocorticism in pregnancy]. 619-23 Ferruti M M MM Speranza R R ita Clinical Trial English Abstract Journal Article

1982 Minerva ginecologica Controlled trial quality: uncertain

12. Sensitivity to cyanocobalamin and hydroxocobalamin. Full Text available with Trip Pro

Sensitivity to cyanocobalamin and hydroxocobalamin. 5572387 1971 06 19 2018 11 13 0007-1447 2 5756 1971 May 01 British medical journal Br Med J Sensitivity to cyanocobalamin and hydroxocobalamin. 262 James J J Warin R P RP eng Journal Article England Br Med J 0372673 0007-1447 P6YC3EG204 Vitamin B 12 Q40X8H422O Hydroxocobalamin AIM IM Administration, Oral Aged Anemia, Pernicious complications Drug Hypersensitivity Dyspnea chemically induced Female Headache chemically induced Humans

1971 British medical journal

13. An assessment of serum 57Co cyanocobalamin as an index of vitamin B12 absorption1 Full Text available with Trip Pro

An assessment of serum 57Co cyanocobalamin as an index of vitamin B12 absorption1 A technique has been developed for accurately assaying serum and urine (57)Co cyanocobalamin during the conventional Schilling test. Serum and urine radioactivity in a large number of patients has been correlated and the precise normal limits have been determined by statistical analysis. The implications of this for investigating conditions other than pernicious anaemia and the malabsorption syndromes are stressed.

1970 Journal of Clinical Pathology

14. An evaluation of simultaneously administered free and intrinsic factor bound radioactive cyanocobalamin in the diagnosis of pernicious anaemia in the elderly Full Text available with Trip Pro

An evaluation of simultaneously administered free and intrinsic factor bound radioactive cyanocobalamin in the diagnosis of pernicious anaemia in the elderly The definitive diagnosis of pernicious anaemia (PA) in the elderly is by no means always straightforward, particularly when inappropriate medication has been introduced before the institution of specific investigatory procedures. A detailed haematological study was carried out on 301 patients aged 60-95 with a serum B(12) concentration

1979 Journal of Clinical Pathology

15. Estimation of intrinsic factor and detection of intrinsic factor antibodies using non-radioactive cyanocobalamin and microbiological assay Full Text available with Trip Pro

Estimation of intrinsic factor and detection of intrinsic factor antibodies using non-radioactive cyanocobalamin and microbiological assay A method employing non-radioactive vitamin B(12) and microbiological assay is described for estimating intrinsic factor in gastric juice and for detecting antibody to intrinsic factor in serum. Satisfactory agreement was obtained between the results by this method and by a modification of the method of Ardeman and Chanarin (1963). During the first hour after

1967 Journal of Clinical Pathology

16. Withdrawal of cyanocobalamin. Full Text available with Trip Pro

Withdrawal of cyanocobalamin. 519368 1980 03 27 2013 11 21 0007-1447 2 6199 1979 Nov 10 British medical journal Br Med J Withdrawal of cyanocobalamin. 1219-20 Davidson N M NM eng Letter England Br Med J 0372673 0007-1447 P6YC3EG204 Vitamin B 12 Q40X8H422O Hydroxocobalamin AIM IM Humans Hydroxocobalamin adverse effects Vitamin B 12 adverse effects 1979 11 10 1979 11 10 0 1 1979 11 10 0 0 ppublish 519368 PMC1597301

1979 British medical journal

17. REQUIREMENT OF SPHAEROTILUS FOR CYANOCOBALAMIN Full Text available with Trip Pro

REQUIREMENT OF SPHAEROTILUS FOR CYANOCOBALAMIN Okrend, Harold (Rutgers, The State University, New Brunswick, N.J.), and Norman C. Dondero. Requirement of Sphaerotilus for cyanocobalamin. J. Bacteriol. 87:286-292. 1964.-Cultures of Sphaerotilus grew well in a culture medium containing pancreatic digest of casein, glycerol, and yeast autolysate, but grew poorly in a defined medium containing monosodium glutamate, glycerol, and salts. Measurement of dry weight, cell nitrogen, and deoxyribonucleic (...) acid showed that the addition of 1.0 mmug/ml of cyancobalamin to the defined medium gave growth equivalent to that obtained with the pancreatic digest of casein. Methionine, in a concentration of 2 x 10(4)-fold, relieved the requirement for cyanocobalamin, but cobalt did not replace cyanocobalamin nor stimulate growth. Of 38 additional cultures of diverse origin, 19 showed stimulation by visible comparison of growth in tubes; nonquantitative comparisons, however, were not reliable for showing

1964 Journal of bacteriology

18. The urinary excretion and tissue retention of cyanocobalamin by subjects given repeated parenteral doses Full Text available with Trip Pro

The urinary excretion and tissue retention of cyanocobalamin by subjects given repeated parenteral doses The urinary excretion of injected cyanocobalamin was studied in 30 previously untreated vitamin B(12)-deficient patients by measuring the urinary radioactivity after repeated injections of (58)Co vitamin B(12). The dose range used was 54 to 30,000 mug., each patient receiving the same dose at each injection. The results show that there is no constant trend to the excretion of greater (...) or smaller proportions of the amount injected. It is also shown that there is a wide variation in the amounts excreted by each individual and between individual patients and that the capacity of the tissues to retain injected cyanocobalamin is very great, the amounts retained often being greatly in excess of the normal body stores. The excretion of radioactivity after parenteral infections of (58)Co vitamin B(12) was usually complete within 24 hours but exceptions to this were seen. The significance

1964 Journal of Clinical Pathology

19. STUDIES ON THE ABSORPTION BY GUINEA PIG INTESTINE OF CYANOCOBALAMIN INCUBATED WITH INTRINSIC FACTOR Full Text available with Trip Pro

STUDIES ON THE ABSORPTION BY GUINEA PIG INTESTINE OF CYANOCOBALAMIN INCUBATED WITH INTRINSIC FACTOR 13881120 1998 11 01 2018 12 01 0021-9738 41 1962 Feb The Journal of clinical investigation J. Clin. Invest. Studies on the absorption by guinea pig intestine of cyanocobalamin incubated with intrinsic factor. 370-7 COOPER B A BA PARANCHYCH W W LOWENSTEIN L L eng Journal Article United States J Clin Invest 7802877 0021-9738 9008-12-2 Intrinsic Factor P6YC3EG204 Vitamin B 12 OM Gastric Fistula

1962 Journal of Clinical Investigation

20. EXCHANGE BETWEEN FREE AND GASTRIC JUICE-BOUND CYANOCOBALAMIN Full Text available with Trip Pro

EXCHANGE BETWEEN FREE AND GASTRIC JUICE-BOUND CYANOCOBALAMIN 14028585 1998 11 01 2018 12 01 0021-9738 42 1963 Apr The Journal of clinical investigation J. Clin. Invest. Exchange between free and gastric juice-bound cyanocobalamin. 534-45 DONALDSON R M RM Jr KATZ J H JH eng Journal Article United States J Clin Invest 7802877 0021-9738 P6YC3EG204 Vitamin B 12 OM Gastric Juice Vitamin B 12 GASTRIC JUICE VITAMIN B 12 1963 4 1 1963 4 1 0 1 1963 4 1 0 0 ppublish 14028585 10.1172/JCI104742 PMC289313

1963 Journal of Clinical Investigation